NCT03541863View on ClinicalTrials.gov

Treatment After Progression of Fulvestrant Among Metastatic Breast Cancer Patients

CompletedOBSERVATIONAL
Enrollment

131

Participants

Timeline

Start Date

October 10, 2017

Primary Completion Date

December 15, 2018

Study Completion Date

December 20, 2018

Conditions
Breast Cancer
Trial Locations (1)

200032

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT03541863 - Treatment After Progression of Fulvestrant Among Metastatic Breast Cancer Patients | Biotech Hunter | Biotech Hunter